Skip to main content
. 2024 Mar 13;67(6):4936–4949. doi: 10.1021/acs.jmedchem.4c00078

Table 3. Compounds Designed to Lower the Clint in Human Hepatocytes.

graphic file with name jm4c00078_0010.jpg

a

Measured inhibition of pAKT formation using alphaLISA after 24 h of treatment.

b

Measured decrease in viability using CellTiter-Glo 2.0 (CTG) after 72 h of treatment.

c

Intrinsic clearance obtained from scaling in vitro half-lives from pooled hepatocytes.